Schedule 13G ownership disclosure
Terns Pharmaceuticals Inc
Common Stock, par value $0.0001 per share · CUSIP: 880881107
Event date: 2025-03-31
- Filing-level shares
- 4,305,204.00
- Percent of class
- 4.93%
- Schonfeld Strategic Advisors LLC
Shares: 4,305,204.00 · Class: 4.93%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193805-25-000669
- Form type
- SCHEDULE 13G/A
- Filer
- Schonfeld Strategic Advisors LLC
- CIK
- CIK 1665241
- Filed
- May 15, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership